Zobrazeno 1 - 10
of 10
pro vyhledávání: '"TECCHUU LEE"'
Autor:
Hiroyasu Yamashiro, Masataka Sawaki, Norikazu Masuda, Yasuhiro Okumura, Toshimi Takano, Eriko Tokunaga, Tsuyoshi Saito, Yasuaki Sagara, Kosuke Yamazaki, Yoshihiro Kawaguchi, Tecchuu Lee, Shinji Ozaki, Kazuhiko Yamagami, Naohito Yamamoto, Katsumasa Kuroi, Hirofumi Suwa, Shoichiro Ohtani, Toshikazu Ito, Shinji Yasuno, Satoshi Morita, Shinji Ohno, Masakazu Toi
Publikováno v:
Breast Cancer: Basic and Clinical Research, Vol 12 (2018)
Background: There are little data on the usefulness of trastuzumab (TZM) retreatment as the first-line treatment for patients with HER2 (human epidermal growth factor receptor 2)–positive breast cancer recurrence after perioperative treatment with
Externí odkaz:
https://doaj.org/article/22b2fb940c0f411cb8432e5a38f4cbc2
Publikováno v:
Anticancer research. 42(8)
Cyclin-dependent kinase (CDK) 4/6 inhibitors have become the standard of care as the first- and second-line treatments for hormone receptor-positive (HR+) or human epidermal growth factor receptor 2 (HER2)-negative metastatic and recurrent breast can
Autor:
Hiroyasu, Yamashiro, Hiroji, Iwata, Norikazu, Masuda, Naohito, Yamamoto, Reiki, Nishimura, Shoichiro, Ohtani, Nobuaki, Sato, Masato, Takahashi, Takako, Kamio, Kosuke, Yamazaki, Tsuyoshi, Saito, Makoto, Kato, Tecchuu, Lee, Katsumasa, Kuroi, Toshimi, Takano, Shinji, Yasuno, Satoshi, Morita, Shinji, Ohno, Masakazu, Toi, Y, Tokunaga
Publikováno v:
Breast Cancer (Tokyo, Japan)
Background Previous large trials of trastuzumab (TZM) demonstrated improved outcomes in patients with HER2-positive early breast cancer. However, its effectiveness and safety in Japanese patients is not yet clear. Recently, new anti-HER2 agents were
Autor:
Yasuo Ueshima, Sachie Tanaka, Yasuhiro Shioaki, Shuhei Komatsu, Keita Minowa, Ken-Ichiro Imura, Eigo Otsuji, Katsumi Shimomura, Tecchuu Lee, Jun Ikeda, Fumihiro Taniguchi, Eito Ikeda, Tatsuya Kumano, Kenichiro Takashina
Publikováno v:
World Journal of Gastrointestinal Surgery
Massive gastrointestinal bleeding from gastrointestinal varices is one of the most serious complications in patients with portal hypertension. However, if no bleeding point can be detected by endoscopy in the predilection sites of gastrointestinal va
Autor:
Hironori Kato, Akira Yamauchi, Tecchuu Lee, Hanae Ueyama, Hiroko Bando, Takayuki Kinoshita, Masakazu Toi, Hiroyasu Yamashiro, Takafumi Ikeda, Kenichi Yoshimura, Katsumasa Kuroi, Nobuhiko Shinkura, Tetsuya Taguchi, Tomoharu Sugie, Terumasa Sawada, Norikazu Masuda
Publikováno v:
Annals of Surgical Oncology. 23:44-50
This study compared the clinical utility of indocyanine green (ICG) fluorescence and radioisotope (RI) for sentinel lymph node (SLN) detection in breast cancer.Women with node-negative breast cancer underwent SLN biopsy using ICG fluorescence and RI.
Autor:
Hirofumi Suwa, Yasuaki Sagara, Tecchuu Lee, Norikazu Masuda, Kazuhiko Yamagami, Yasuhiro Okumura, Shinji Ohno, Tsuyoshi Saito, Naoki Yamamoto, Hiroyasu Yamashiro, Yoshihiro Kawaguchi, Kosuke Yamazaki, Masakazu Toi, Shinji Ozaki, Toshikazu Ito, Katsumasa Kuroi, Masataka Sawaki, Satoshi Morita, Eriko Tokunaga, Shinji Yasuno, Shoichiro Ohtani, Toshimi Takano
Publikováno v:
Breast Cancer: Basic and Clinical Research, Vol 12 (2018)
Breast Cancer : Basic and Clinical Research
Breast Cancer : Basic and Clinical Research
Background: There are little data on the usefulness of trastuzumab (TZM) retreatment as the first-line treatment for patients with HER2 (human epidermal growth factor receptor 2)–positive breast cancer recurrence after perioperative treatment with
Autor:
Hiroyasu, Yamshiro, Hiroji, Iwata, Norikazu, Masuda, Naohito, Yamamoto, Reiki, Nishimura, Shoichiro, Ohtani, Nobuaki, Sato, Nobuki, Sato, Masato, Takahashi, Takako, Kamio, Kosuke, Yamazaki, Tsuyoshi, Saito, Makoto, Kato, Tecchuu, Lee, Shinji, Ohno, Katsumasa, Kuroi, Toshimi, Takano, Masahiro, Takada, Shinji, Yasuno, Satoshi, Morita, Masakazu, Toi
Publikováno v:
International journal of clinical oncology. 20(4)
Previous large trials with trastuzumab (TZM) showed improved outcome in patients with HER2-positive early-stage breast cancer. However, the efficacy and safety of TZM in Japanese patients have not been fully evaluated. We have therefore conducted an
Autor:
Kosuke Yamazaki, Toshimi Takano, Masato Takahashi, Masahiro Takada, Hiroji Iwata, Shoichiro Ohtani, Tsuyoshi Saito, Katsumasa Kuroi, Reiki Nishimura, Naohito Yamamoto, Tecchuu Lee, Masakazu Toi, Shinji Yasuno, Makoto Kato, Hiroyasu Yamshiro, Shinji Ohno, Takako Kamio, Satoshi Morita, Norikazu Masuda, Nobuaki Sato
Publikováno v:
International Journal of Clinical Oncology. 20:723-724
Autor:
Fumitaka Mutou, Takao Ouchi, Kiyokazu Akioka, Tsutomu Matsushita, Yasuo Ueshima, Genko Ishimine, Tecchuu Lee, Eito Ikeda, Yasuhiro Shioaki, Hideaki Kurioka, Hiroyuki Makino
Publikováno v:
The journal of the Japanese Practical Surgeon Society. 57:1112-1115
Autor:
Tomoharu Sugie, Takayuki Kinoshita, Nobuhiko Shinkura, Tetsuya Taguchi, Hanae Ueyama, Hiroko Bando, Katsumasa Kuroi, Hironori Kato, Takafumi Ikeda, Akira Yamauchi, Masakazu Toi, Terumasa Sawada, Norikazu Masuda, Kenichi Yoshimura, Tecchuu Lee, Hiroyasu Yamashiro
Publikováno v:
Journal of Clinical Oncology. 32:1091-1091
1091 Background: Near-infrared fluorescence signal of indocyanien green (ICG) can visualize subcutaneous lymphatic flows and draining (sentinel) lymph nodes (SLNs). In fluorescence ICG Breast Study...